FIELD: pharmaceutical chemistry.
SUBSTANCE: group of inventions includes a compound of formula (I), its pharmaceutically acceptable salts, enantiomers, dihydrate (S)-N-methyl-N-(6-methyl-2-((4aS,5aR)-5a-methyl-1,4,4a,5,5a,6-hexahydrocyclopropa[f]indazol-3-yl)-1H-benzo[d]imidazol-5-yl)-2-morpholinopropanamide, pharmaceutical composition and the use based on them. In formula (I), each R1 is independently H or F; R2 is either H or (C1-C4)alkyl; each R3 is independently H, F or (C1-C4)alkyl; R5 and R6 independently represent H; halogen; OH; CN; (C1-C6)alkyl; hydroxy(C1-C6)alkyl; (C1-C4)alkoxy(C1-C6)alkyl; (C1-C6)alkyl substituted with one, two or three F; (C1-C6)alkoxy; or (C1-C6)alkoxy substituted with (C1-C4)alkoxy; R4 is selected from or , each of which is optionally substituted with one or two substituents independently selected from oxo, (C1-C4)alkyl and hydroxy(C1-C4) alkyl.
EFFECT: benzimidazole derivatives exhibiting properties of ITK inhibitors.
26 cl, 7 dwg, 4 tbl, 56 ex
Title | Year | Author | Number |
---|---|---|---|
C-3 AND C-17 MODIFIED TRITERPENOIDS AS HIV-1 INHIBITORS | 2017 |
|
RU2716502C2 |
MODULATORS OF INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASE | 2007 |
|
RU2459821C2 |
BICYCLIC ARYL MONOBACTAM COMPOUNDS AND METHODS OF USING SAID COMPOUNDS FOR TREATING BACTERIAL INFECTIONS | 2017 |
|
RU2733402C2 |
TRICYCLIC COMPOUND AND JAK INHIBITOR | 2015 |
|
RU2674262C2 |
BENZIMIDAZOLE DERIVATIVES AS ROR-GAMMA MODULATORS | 2017 |
|
RU2760366C2 |
AMINOTRIAZOLOPYRIDINES AND USING THEM AS KINASE INHIBITORS | 2009 |
|
RU2552642C2 |
DUAL-ACTING ANTIHYPERTENSIVE COMPOUNDS, METHODS FOR PREPARING THEM, BASED PHARMACEUTICAL COMPOSITIONS AND INTERMEDIATE COMPOUNDS | 2008 |
|
RU2476427C2 |
NITROOXY-DERIVATIVES OF LOSARTAN, VALSARTAN, CANDESARTAN, TELMISARTAN EPROSARTAN AND OLMESARTAN AS BLOCKERS OF ANGIOTENSIN II RECEPTORS FOR TREATING CARDIOVASCULAR DISEASES | 2004 |
|
RU2374240C2 |
PYRUVATEKINASE MODULATORS AND THEIR USE | 2018 |
|
RU2797518C2 |
3-AMINOPYRROLIDINE DERIVATIVES AS CHEMOKINE RECEPTOR MODULATORS | 2003 |
|
RU2355679C2 |
Authors
Dates
2023-09-12—Published
2020-12-16—Filed